Seaford Pharmaceuticals

Seaford Pharmaceuticals, established in 1991, is a Canadian family business committed to advancing healthcare solutions for over three decades. Our dedication to health is evident through collaborative efforts with strategic partners, facilitating the development of niche products in therapeutic areas like iron deficiency, anemia, hyperhidrosis, and hyperpigmentation.

Within our Canadian portfolio are hospital products such as Seacalphyx, BTC products and Polyride Fe, and K-Citra, as well as the widely recognized OTC antiperspirant DRYSOL, all working hard to earn trust in hospitals and healthcare settings alike.

Guided by a knowledgeable leadership team immersed in the pharmaceutical industry, our sales force actively cultivates strong relationships with pharmacists, specialists, and family physicians. This collaborative approach ensures customized healthcare solutions that cater to patients’ diverse and evolving needs.

At Seaford Pharmaceuticals, our commitment extends beyond experience, encompassing the active cultivation of a culture of mentorship and support for new graduates, interns, and co-op students. This dedication to knowledge sharing and mentorship, coupled with an unwavering commitment to fostering a positive workplace environment for our dedicated employees, has earned us the prestigious Great Place to Work certificate for the second consecutive year.

Our vision is clear: to be a market leader, providing high-value healthcare products that significantly improve patient outcomes. This commitment is driven by our dedication to bringing top-quality, patient-centric healthcare products to the global market, ensuring the well-being of individuals worldwide. Our core values of teamwork, accountability, and excellence serve as the foundation for a culture of innovation and an unwavering commitment to improving the health and lives of those we serve.